Cite
HARVARD Citation
Nakayama, M. et al. (2023). A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine. Ocular immunology and inflammation. pp. 462-467. [Online].